Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2023

Sep 6, 2023

30786_dirs_2023-09-06_c7182eb1-b790-4da1-a595-a351b2f12d6f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-09-01

Reporting Person: Daskal Ilan (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-01 Bio-Rad A Common Stock M 694 Acquired 2206.212 Direct
2023-09-01 Bio-Rad A Common Stock F 240 $394.60 Disposed 1966.212 Direct
2023-09-01 Bio-Rad A Common Stock M 456 Acquired 2422.212 Direct
2023-09-01 Bio-Rad A Common Stock F 209 $394.60 Disposed 2213.212 Direct
2023-09-02 Bio-Rad A Common Stock M 542 Acquired 2755.212 Direct
2023-09-02 Bio-Rad A Common Stock F 269 $394.60 Disposed 2486.212 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-09-01 Restricted Stock Units $0 A 4007 Acquired Bio-Rad A Common Stock (4007) Direct
2023-09-01 Restricted Stock Units $0 M 694 Disposed Bio-Rad A Common Stock (694) Direct
2023-09-01 Restricted Stock Units $0 M 456 Disposed Bio-Rad A Common Stock (456) Direct
2023-09-02 Restricted Stock Units $0 M 542 Disposed Bio-Rad A Common Stock (542) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 18.9440 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F5: On September 1, 2022, the reporting person was granted 2,776 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F6: On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F7: On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.